Yes. I watched the webinar.
I didn't realise that the historic trials covered dosing of over 2,000 patients. Quite incredible. The other historical statistic was I think 4% of patients with heart failure from Bisantrene versus around 25% for Doxorubicin.
Do some research for yourself on the number of Breast Cancer chemotherapy regimens that use Doxorubicin (aka Adriamycin).
RAC Charts, page-1299
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |